Heat shock protein–based therapy as a potential candidate for treating the sphingolipidoses

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189

Repertoires of Autophagy in the Pathogenesis of Ocular Diseases

Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351

Induction of the Vitamin D Receptor Attenuates Autophagy Dysfunction-Mediated Cell Death Following Traumatic Brain Injury

Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, R. C., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,214

Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data

Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,565

The role of autophagy in neurodegenerative disease

Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059

Niemann-Pick disease type C

Vanier, M. T. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-16 · Cited by 1,222

The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions

Daugaard, M., Rohde, M., & Jäättelä, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.039 · Cited by 1,177

Modulation of neurodegeneration by molecular chaperones

Muchowski, P. J., & Wacker, J. L. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1587 · Cited by 1,043

A Cross-Sectional Study

Drozdzowska, B., Pluskiewicz, W., Halaba, Z. P., Misiołek, H., & Beck, B. R. (2005) · Cited by 984

CD91 Is a Common Receptor for Heat Shock Proteins gp96, hsp90, hsp70, and Calreticulin

Basu, S., Binder, R. J., Ramalingam, T., & Srivastava, P. K. (2001) · Immunity · doi:10.1016/s1074-7613(01)00111-x · Cited by 900

Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging

Morimoto, R. I. (2008) · Genes & Development · doi:10.1101/gad.1657108 · Cited by 872

Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.

Marber, M. S., Mestril, R., H, S., Sayen, M. R., Yellon, D. M., & DILLMANN, W. H. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117815 · Cited by 843

Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium

Lloyd‐Evans, E., Morgan, A. J., He, X., Smith, D. A., Elliot-Smith, E., Sillence, D. J., Churchill, G. C., Schuchman, E. H., Galione, A., & Platt, F. M. (2008) · Nature Medicine · doi:10.1038/nm.1876 · Cited by 832

Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases

Gabathuler, R. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.028 · Cited by 829

Regulation of H SF 1 Function in the Heat Stress Response: Implications in Aging and Disease

Anckar, J., & Sistonen, L. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060809-095203 · Cited by 811

Murine Model of Niemann-Pick C Disease: Mutation in a Cholesterol Homeostasis Gene

Loftus, S. K., Morris, J. A., Carstea, E. D., Gu, J. Z., Cummings, C., Brown, A., Ellison, J., Ohno, K., Rosenfeld, M. A., Tagle, D. A., et al. (1997) · Science · doi:10.1126/science.277.5323.232 · Cited by 798

Lysosomes in cell death

Guicciardi, M. E., Leist, M., & Gores, G. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207512 · Cited by 731

Chaperoning signaling pathways: molecular chaperones as stress-sensing`heat shock' proteins

Nollen, E. A. A., & Morimoto, R. I. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.14.2809 · Cited by 644

Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2

Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557

Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery.

Plumier, J.-C., Ross, B. M., Currie, R. W., Angelidis, C., kazlaris, H., Kollias, G. A., & Pagoulatos, G. N. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117865 · Cited by 553

Heat Shock Protein 70 Promotes Cell Survival by Inhibiting Lysosomal Membrane Permeabilization

Nylandsted, J., Gyrd-Hansen, M., Danielewicz, A., Fehrenbacher, N., Lademann, U., Høyer-Hansen, M., Weber, E., Multhoff, G., Rohde, M., & Jäättelä, M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040531 · Cited by 545

Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice

Kieran, D., Kalmár, B., Dick, J. R. T., Riddoch‐Contreras, J., Burnstock, G., & Greensmith, L. (2004) · Nature Medicine · doi:10.1038/nm1021 · Cited by 522

Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology

Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519

Protein Quality Control in the Cytosol and the Endoplasmic Reticulum: Brothers in Arms

Buchberger, A., Bukau, B., & Sommer, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.001 · Cited by 483

Heat shock proteins as cellular lifeguards

Jäättelä, M. (1999) · Annals of Medicine · doi:10.3109/07853899908995889 · Cited by 482

Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism

Sango, K., Yamanaka, S., Hoffmann, A., Okuda, Y., Grinberg, A., Westphal, H., McDonald, M. P., Crawley, J. N., Sandhoff, K., Suzuki, K., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-170 · Cited by 468

PRINCIPLES OF LYSOSOMAL MEMBRANE DIGESTION: Stimulation of Sphingolipid Degradation by Sphingolipid Activator Proteins and Anionic Lysosomal Lipids

Kolter, T., & Sandhoff, K. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.120013 · Cited by 464

Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins

Triguero, D., Buciak, J. L., & Pardridge, W. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04886.x · Cited by 454

Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression

Davidson, C. D., Ali, N. F., Micsenyi, M. C., Stephney, G. W., Renault, S., Dobrenis, K., Ory, D. S., Vanier, M. T., & Walkley, S. U. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006951 · Cited by 449

The Heat Shock Response: Systems Biology of Proteotoxic Stress in Aging and DiseasePreprint

Morimoto, R. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010637 · Cited by 419

Lysosomal storage diseases: from pathophysiology to therapy

Parenti, G., Andria, G., & Ballabio, A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-122313-085916 · Cited by 404

Lysosomal involvement in cell death and cancer

Kirkegaard, T., & Jäättelä, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.008 · Cited by 401

α-Galactosidase A deficient mice: A model of Fabry disease

Ohshima, T., Murray, G. J., Swaim, W. D., Longenecker, G., Quirk, J. M., CARDARELLI, C. O., Sugimoto, Y., Pastan, I. H., Gottesman, M. M., Brady, R. O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2540 · Cited by 366

Chemical and Biological Approaches Synergize to Ameliorate Protein-Folding Diseases

Mu, T., Ong, D. S. T., Wang, Y., Balch, W. E., Yates, J. R., Segatori, L., & Kelly, J. W. (2008) · Cell · doi:10.1016/j.cell.2008.06.037 · Cited by 359

CD40, an extracellular receptor for binding and uptake of Hsp70–peptide complexes

Becker, T., Hartl, F. U., & Wieland, F. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200208083 · Cited by 356

Transformation-Associated Changes in Sphingolipid Metabolism Sensitize Cells to Lysosomal Cell Death Induced by Inhibitors of Acid Sphingomyelinase

Petersen, N. H. T., Olsen, O. D., Groth‐Pedersen, L., Ellegaard, A., Bilgin, M., Redmer, S., Ostenfeld, M. S., Ulanet, D., Dovmark, T. H., Lønborg, A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.08.003 · Cited by 344

Critical role for glycosphingolipids in Niemann-Pick disease type C

Zervas, M., Somers, K. L., Thrall, M. A., & Walkley, S. U. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00396-7 · Cited by 324

Sphingolipid lysosomal storage disorders

Platt, F. M. (2014) · Nature · doi:10.1038/nature13476 · Cited by 318

Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases

Neef, D. W., Jaeger, A. M., & Thiele, D. J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3453 · Cited by 316

GM1-Ganglioside Accumulation at the Mitochondria-Associated ER Membranes Links ER Stress to Ca2+-Dependent Mitochondrial Apoptosis

Sano, R., Annunziata, I., Patterson, A. E., Moshiach, S., Gomero, E. M., Opferman, J. T., Forte, M. A., & d’Azzo, A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.021 · Cited by 301

Bimoclomol: A nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects

Vígh, L., Literáti, P. N., Horváth, I., Török, Z., Balogh, G. E., Glatz, A., Kovács, E., Boros, I., Ferdinándy, P., Parkas, B., et al. (1997) · Nature Medicine · doi:10.1038/nm1097-1150 · Cited by 278

Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N -butyldeoxynojirimycin

Jeyakumar, M., Butters, T. D., Cortina‐Borja, M., Hunnam, V., Proia, R. L., Perry, V. H., Dwek, R. A., & Platt, F. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6388 · Cited by 267

The role of glycosphingolipid metabolism in the developing brain

Yu, R. K., Nakatani, Y., & Yanagisawa, M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800028-jlr200 · Cited by 267

Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff Diseases

Phaneuf, D., Wakamatsu, N., Huang, J., Borowski, A., Peterson, A. C., Fortunato, S. R., Ritter, G., Igdoura, S. A., Morales, C. R., Benoit, G., et al. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.1.1 · Cited by 257

Hsp72 preserves muscle function and slows progression of severe muscular dystrophy

Gehrig, S. M., van der Poel, C., Sayer, T. A., Schertzer, J. D., Henstridge, D. C., Church, J. E., Lamon, S., Russell, A. P., Davies, K. E., Febbraio, M. A., et al. (2012) · Nature · doi:10.1038/nature10980 · Cited by 250

Lysobisphosphatidic Acid Controls Endosomal Cholesterol Levels

Chevallier, J., Chamoun, Z., Jiang, G., Prestwich, G. D., Sakai, N., Matile, S., Parton, R. G., & Grüenberg, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801463200 · Cited by 233

GM1-Ganglioside-Mediated Activation of the Unfolded Protein Response Causes Neuronal Death in a Neurodegenerative Gangliosidosis

Tessitore, A., Martin, M. D. P., Sano, R., Ma, Y., Männ, L., Ingrassia, A. M. T., Laywell, E. D., Steindler, D. A., Hendershot, L. M., & d’Azzo, A. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.029 · Cited by 226

Secondary lipid accumulation in lysosomal disease

Walkley, S. U., & Vanier, M. T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.014 · Cited by 215

Fabry Disease: Preclinical Studies Demonstrate the Effectiveness of α-Galactosidase A Replacement in Enzyme-Deficient Mice

Ioannou, Y. A., Zeidner, K. M., Gordon, R. E., & Desnick, R. J. (2001) · The American Journal of Human Genetics · doi:10.1086/316953 · Cited by 199

Lipids on Trial: The Search for the Offending Metabolite in Niemann-Pick type C Disease

Lloyd‐Evans, E., & Platt, F. M. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01032.x · Cited by 199

Lipid Changes in Niemann-Pick Disease Type C Brain: Personal Experience and Review of the Literature

Vanier, M. T. (1999) · Neurochemical Research · doi:10.1023/a:1022575511354 · Cited by 197

Interaction of Heat Shock Protein 70 Peptide with NK Cells Involves the NK Receptor CD94

Groß, C. C., Hansch, D., Gastpar, R., & Multhoff, G. (2003) · Biological Chemistry · doi:10.1515/bc.2003.030 · Cited by 194

A genetic storage disorder in BALB/C mice with a metabolic block in esterification of exogenous cholesterol.

Pentchev, P. G., Boothe, A. D., Kruth, H. S., Weintroub, H., Stivers, J. A., & Brady, R. O. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91082-3 · Cited by 184

Histone deacetylase inhibitor treatment dramatically reduces cholesterol accumulation in Niemann-Pick type C1 mutant human fibroblasts

Pipalia, N. H., Cosner, C. C., Huang, A., Chatterjee, A., Bourbon, P., Farley, N., Helquist, P., Wiest, O., & Maxfield, F. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014890108 · Cited by 180

Tumor necrosis factor-α-associated lysosomal permeabilization is cathepsin B dependent

Werneburg, N. W., Guicciardi, M. E., Bronk, S. F., & Gores, G. J. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00151.2002 · Cited by 179

Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling

Neville, D. C. A., Coquard, V., Priestman, D. A., Vruchte, D. T., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178

Multi-system disorders of glycosphingolipid and ganglioside metabolism

Xu, Y.-H., Barnes, S., Sun, Y., & Grabowski, G. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.r003996 · Cited by 171

Niemann-Pick Type C1 I1061T Mutant Encodes a Functional Protein That Is Selected for Endoplasmic Reticulum-associated Degradation Due to Protein Misfolding

Gelsthorpe, M. E., Baumann, N. A., Millard, E. E., Gale, S. E., Langmade, S. J., Schaffer, J. E., & Ory, D. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708735200 · Cited by 169

Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS

Kalmár, B., Novoselov, S. S., Gray, A. L., Cheetham, M. E., Margulis, B. A., & Greensmith, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05595.x · Cited by 166

Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation

Abe, A., Gregory, S., Lee, L., Killen, P. D., Brady, R. O., Kulkarni, A. B., & Shayman, J. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9711 · Cited by 161

Niemann-Pick disease type C symptomatology: an expert-based clinical description

Mengel, E., Klünemann, H.-H., Lourenço, C. M., Hendriksz, C. J., Sedel, F., Walterfang, M., & Kolb, S. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-166 · Cited by 157

Lysosomal Degradation on Vesicular Membrane Surfaces

Wilkening, G., Linke, T. A., & Sandhoff, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30271 · Cited by 156

Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals

Speak, A. O., Salio, M., Neville, D. C. A., Fontaine, J., Priestman, D. A., Platt, N., Heare, T., Butters, T. D., Dwek, R. A., Trottein, F., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607285104 · Cited by 152

Brain gangliosides in axon–myelin stability and axon regeneration

Schnaar, R. L. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.011 · Cited by 152

Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation

Ostenfeld, M. S., Høyer-Hansen, M., Bastholm, L., Fehrenbacher, N., Olsen, O. D., Groth-Pedersen, L., Puustinen, P., Kirkegaard-Sørensen, T., Nylandsted, J., Farkas, T., et al. (2008) · Autophagy · doi:10.4161/auto.5774 · Cited by 142

The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol

Kalmár, B., Lu, C., & Greensmith, L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.08.003 · Cited by 135

Exogenous Delivery of Heat Shock Protein 70 Increases Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis

Gifondorwa, D. J., Robinson, M., Hayes, C. D., Taylor, A. R., Prevette, D. M., Oppenheim, R. W., Caress, J. B., & Milligan, C. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4057-07.2007 · Cited by 134

Targeting protein homeostasis in sporadic inclusion body myositis

Ahmed, M., Machado, P., Miller, A., Spicer, C., Herbelin, L. L., He, J., Noel, J., Wang, Y., McVey, A., Pasnoor, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4583 · Cited by 131

Implications for Therapy

Pandrea, I., & LANDAY, A. L. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-387715-4.00003-4 · Cited by 128

Interfacial Regulation of Acid Ceramidase Activity

Linke, T. A., Wilkening, G., Sadeghlar, F., Mozcall, H., Bernardo, K., Schuchman, E. H., & Sandhoff, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006846200 · Cited by 126

A Murine Niemann-Pick C1 I1061T Knock-In Model Recapitulates the Pathological Features of the Most Prevalent Human Disease Allele

Praggastis, M., Tortelli, B. A., Zhang, J., Fujiwara, H., Sidhu, R., Chacko, A., Chen, Z., Chung, C., Lieberman, A. P., Sikora, J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4173-14.2015 · Cited by 121

Stimulation of Acid Sphingomyelinase Activity by Lysosomal Lipids and Sphingolipid Activator Proteins

Linke, T. A., Wilkening, G., Lansmann, S., Moczall, H., Bartelsen, O., Weisgerber, J., & Sandhoff, K. (2001) · Biological Chemistry · doi:10.1515/bc.2001.035 · Cited by 118

Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies

Aerts, J. M. F. G., Kallemeijn, W. W., Wegdam, W., Ferraz, M. J., van Breemen, M. J., Dekker, N., Kramer, G., Poorthuis, B. J. H. M., Groener, J. E. M., Cox‐Brinkman, J., et al. (2011) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9308-6 · Cited by 118

Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis

Cudkowicz, M., Shefner, J. M., Simpson, E., Grasso, D., Yu, H., Zhang, H., Shui, A. M., Schoenfeld, D., Brown, R. H., Wieland, S., et al. (2008) · Muscle & Nerve · doi:10.1002/mus.21059 · Cited by 110

Accumulation of cholera toxin and GM1 ganglioside in the early endosome of Niemann–Pick C1-deficient cells

Sugimoto, Y., Ninomiya, H., Ohsaki, Y., Higaki, K., Davies, J. P., Ioannou, Y. A., & Ohno, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221181998 · Cited by 105

White and gray matter alterations in adults with Niemann-Pick disease type C

Walterfang, M., Fahey, M. C., Desmond, P. M., WOOD, A. G., Seal, M. L., Steward, C. E., Adamson, C. L., Kokkinos, C., Fietz, M., & Velakoulis, D. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e6210e · Cited by 105

Npc1 Acting in Neurons and Glia Is Essential for the Formation and Maintenance of CNS Myelin

Yu, T., & Lieberman, A. P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003462 · Cited by 103

Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling

de Lange, E. C. M., Ravenstijn, P. G. M., Groenendaal, D., & van Steeg, T. J. (2005) · The AAPS Journal · doi:10.1208/aapsj070354 · Cited by 94

Miglustat Improves Purkinje Cell Survival and Alters Microglial Phenotype in Feline Niemann-Pick Disease Type C

Stein, V. M., Crooks, A. V., Ding, W., Prociuk, M. L., O’Donnell, P., Bryan, C., Sikora, T. U., Dingemanse, J., Vanier, M. T., Walkley, S. U., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825414a6 · Cited by 94

Degradation of Membrane-bound Ganglioside GM1

Wilkening, G., Linke, T. A., Uhlhorn-Dierks, G., & Sandhoff, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006568200 · Cited by 93

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis

Elliot-Smith, E., Speak, A. O., Lloyd‐Evans, E., Smith, D. A., van der Spoel, A. C., Jeyakumar, M., Butters, T. D., Dwek, R. A., d’Azzo, A., & Platt, F. M. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.02.005 · Cited by 84

Improvement in Lipid and Protein Trafficking in NPC1 Cells by Correction of a Secondary Enzyme Defect

Devlin, C. M., Pipalia, N. H., Liao, X., Schuchman, E. H., Maxfield, F. R., & Tabas, I. A. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01046.x · Cited by 84

Perturbed Myelination Process of Premyelinating Oligodendrocyte in Niemann-PickType C Mouse

Takikita, S., Fukuda, T., Mohri, I., Yagi, T., & Suzuki, K. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.660 · Cited by 78

Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones

Yang, C., Rahimpour, S., Lu, J., Pacák, K., Ikejiri, B. L., Brady, R. O., & Zhuang, Z. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221046110 · Cited by 76

Saposin A Mobilizes Lipids from Low Cholesterol and High Bis(monoacylglycerol)phosphate-containing Membranes

Locatelli‐Hoops, S., Remmel, N., Klingenstein, R., Breiden, B., Rossocha, M., Schoeniger, M., Koenigs, C., Saenger, W., & Sandhoff, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607281200 · Cited by 73

Relative acidic compartment volume as a lysosomal storage disorder–associated biomarker

te Vruchte, D., Speak, A. O., Wallom, K. L., Al Eisa, N., Smith, D. A., Hendriksz, C. J., Simmons, L., Lachmann, R. H., Cousins, A., Hartung, R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72835 · Cited by 73

Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for neuroprotective and neurotoxic effects

Kalmár, B., & Greensmith, L. (2009) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-009-0002-8 · Cited by 69

Endoplasmic Reticulum-associated Degradation of Niemann-Pick C1

Nakasone, N., Nakamura, Y. S., Higaki, K., Oumi, N., Ohno, K., & Ninomiya, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.549915 · Cited by 65

Upregulation of Heat Shock Proteins Rescues Motoneurones from Axotomy-Induced Cell Death in Neonatal Rats

Kalmár, B., Burnstock, G., Vrbovà, G., Urbanics, R., Csermely, P., & Greensmith, L. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7945 · Cited by 65

Hydroximic Acid Derivatives: Pleiotropic Hsp Co-Inducers Restoring Homeostasis and Robustness

Crul, T., Tóth, N., Piotto, S., Literati-Nagy, P., Tory, K., Haldimann, P., Kalmár, B., Greensmith, L., Török, Z., Balogh, G. E., et al. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804143716 · Cited by 64

Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann–Pick C mice

Nietupski, J. B., Pacheco, J., Chuang, W., Maratea, K. A., Li, L., Foley, J., Ashe, K. M., Cooper, C. G. F., Aerts, J. M. F. G., Copeland, D., et al. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.01.020 · Cited by 64

Co-induction of the heat shock response ameliorates disease progression in a mouse model of human spinal and bulbar muscular atrophy: implications for therapy

Malik, B. A., Nirmalananthan, N., Gray, A. L., Spada, A. R. L., Hanna, M. G., & Greensmith, L. (2013) · Brain · doi:10.1093/brain/aws343 · Cited by 64

The heat-shock response co-inducer arimoclomol protects against retinal degeneration in rhodopsin retinitis pigmentosa

Parfitt, D. A., Aguilà, M., McCulley, C. H., Bevilacqua, D., Mendes, H. F., Athanasiou, D., Novoselov, S. S., Kanuga, N., Munro, P., Coffey, P. J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.214 · Cited by 63

Lysosomal Membrane Permeability Stimulates Protein Aggregate Formation in Neurons of a Lysosomal Disease

Micsenyi, M. C., Sikora, J., Stephney, G. W., Dobrenis, K., & Walkley, S. U. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0987-13.2013 · Cited by 58

Effect of sialoadenectomy and salivary gland extracts on gastrointestinal mucosal growth and gastrin levels in the rat.

Skinner, K. A., Soper, B. D., & Tepperman, B. L. (1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015227 · Cited by 54

Arimoclomol: a potential therapy under development for ALS

Lanka, V., Wieland, S., Barber, J. R., & Cudkowicz, M. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903357486 · Cited by 53

Effect of BRX‐220 against Peripheral Neuropathy and Insulin Resistance in Diabetic Rat Models

Kurthy, M., MOGYORÓSI, T., NAGY, K., Kukorelli, T., Jednákovits, A., Tálosi, L., & BÍRÓ, K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04306.x · Cited by 53

Human heat shock protein 70 (Hsp70) as a peripheral membrane protein

Mahalka, A. K., Kirkegaard, T., Jukola, L. T. I., Jäättelä, M., & Kinnunen, P. K. J. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.01.022 · Cited by 52

Brothers in arms.

Martini, C. D. (2008) · PubMed · Cited by 48

Size and Shape of the Corpus Callosum in Adult Niemann-Pick Type C Reflects State and Trait Illness Variables

Walterfang, M., Fahey, M. C., Abel, L. A., Fietz, M., WOOD, A. G., Bowman, E. A., Reutens, D. C., & Velakoulis, D. (2011) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2490 · Cited by 47

Pontine‐to‐midbrain ratio indexes ocular‐motor function and illness stage in adult Niemann–Pick disease type C

Walterfang, M., Macfarlane, M. D., Looi, J. C., Abel, L. A., Bowman, E. A., Fahey, M. C., Desmond, P. M., & Velakoulis, D. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03545.x · Cited by 46

Lysosomal storage diseases and the heat shock response: convergences and therapeutic opportunities

Ingemann, L., & Kirkegaard, T. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r048090 · Cited by 44

Heat Shock Protein 70.1 (Hsp70.1) Affects Neuronal Cell Fate by Regulating Lysosomal Acid Sphingomyelinase

Zhu, H., Yoshimoto, T., & Yamashima, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.560334 · Cited by 44

Studies on human liver alpha-galactosidases. II. Purification and enzymatic properties of alpha-galactosidase B (alpha-N-acetylgalactosaminidase).

Dean, K. J., & Sweeley, C. C. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86664-4 · Cited by 43

Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones

Yang, C., Swallows, C. L., Zhang, C., Lu, J., Xiao, H., Brady, R. O., & Zhuang, Z. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321341111 · Cited by 43

Spontaneous Activation of Pancreas Trypsinogen in Heat Shock Protein 70.1 Knock-out Mice

Hwang, J., Ryu, J. K., Yoon, Y. B., Lee, K. H., Park, Y.-S., Kim, J., Kim, N., Lee, D. H., Jeong, J. B., Seo, J., et al. (2005) · Pancreas · doi:10.1097/01.mpa.0000183377.04295.c3 · Cited by 38

Animal models for metabolic, neuromuscular and ophthalmological rare diseases

Vaquer, G., Rivière, F., Mavris, M., Bignami, F., Llinares, J., Westermark, K., & Sepodes, B. M. N. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3831 · Cited by 37

Decreased expression of myelin gene regulatory factor in Niemann-Pick type C 1 mouse

Yan, X., Lukáš, J., Witt, M., Wree, A., Hübner, R., Frech, M. J., Köhling, R., Rolfs, A., & Luo, J. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9263-9 · Cited by 33

Emerging therapies and therapeutic concepts for lysosomal storage diseases

Kirkegaard, T. (2013) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2013.780970 · Cited by 32

Microdialysis Evaluation of Clozapine and N-Desmethylclozapine Pharmacokinetics in Rat Brain

Cremers, T. I. F. H., Flik, G., Hofland, C. M., & Stratford, R. E. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045682 · Cited by 29

HSP70 and lysosomal storage disorders: novel therapeutic opportunities

Petersen, N. H. T., & Kirkegaard, T. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381479 · Cited by 28

The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann–Pick type C patients carrying missense mutations

Macías‐Vidal, J., Girós, M., Guerrero‐Hernández, M., Gascón, P., Serratosa, J., Bachs, O., & Coll, M. J. (2014) · FEBS Journal · doi:10.1111/febs.12954 · Cited by 26

Treatment of Human Fibroblasts Carrying NPC1 Missense Mutations with MG132 Leads to an Improvement of Intracellular Cholesterol Trafficking

Zampieri, S., Bembi, B., Rosso, N., Filocamo, M., & Dardis, A. (2011) · JIMD Reports · doi:10.1007/8904_2011_49 · Cited by 24

Pharmacokinetic and Tissue Distribution Mechanism of Mouse Recombinant Heat Shock Protein 70 in Mice

Takemoto, S., Nishikawa, M., & Takakura, Y. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1880-0 · Cited by 24

The therapeutic potential of pharmacological chaperones and proteosomal inhibitors, Celastrol and MG132 in the treatment of sialidosis

O’Leary, E. M., & Igdoura, S. A. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.07.013 · Cited by 24

Treatment for familial amyotrophic lateral sclerosis/motor neuron disease

Benatar, M. G., Kurent, J. E., & Moore, D. H. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006153.pub2 · Cited by 9

Treatment for familial amyotrophic lateral sclerosis/motor neuron disease

Benatar, M. G., Kurent, J. E., & Moore, D. H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006153 · Cited by 1

Proceedings of the Physiological Society, 24‐25 February 1984, Imperial College Meeting: Demonstrations

(1984) · The Journal of Physiology · doi:10.1113/jphysiol.1984.sp015272 · Cited by 1

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.

Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680

Lysosomal storage diseases

Platt, F. M., d’Azzo, A., Davidson, B. L., Neufeld, E. F., & Tifft, C. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0025-4 · Cited by 1,052

LYSOSOMAL STORAGE DISEASES

Neufeld, E. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.001353 · Cited by 924

Lysosomal membrane permeabilization and cell death

Wang, F., Gómez‐Sintes, R., & Boya, P. (2018) · Traffic · doi:10.1111/tra.12613 · Cited by 804

Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG

Gu, Y., Liu, Y., Fu, L., Zhai, L., Zhu, J., Han, Y., Jiang, Y., Zhang, Y., Zhang, P., Jiang, Z., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0309-y · Cited by 264

HSP70 reverses lysosomal pathology

Crunkhorn, S. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.220 · Cited by 2

Modulating the heat-shock response : a potential therapy for lysosomal storage disorders

Gray, J. A. R. (2014) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-gp70p2zao

Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology

Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519

Heat shock protein 70 (Hsp70)

(2010) · Science-Business eXchange · doi:10.1038/scibx.2010.193

Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases

Hemsley, K. M., & Hopwood, J. J. (2009) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp47118 · Cited by 29